Mikael Eriksson

affiliated with the university
More filtering options
  1. 2019
  2. Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort

    et al., Smeland, S., Mikael Eriksson, Sydes, M. R. & Marina, N., 2019, In : European Journal of Cancer. 109, p. 36-50 15 p.

    Research output: Contribution to journalArticle

  3. Tobacco smoking and alcohol consumption as risk factors for thymoma – A European case-control study

    Mikael Eriksson, Kaerlev, L., Johansen, P., Afonso, N., Ahrens, W., Costa-Pereira, A., Guénel, P., Jöckel, K. H., Gonzalez, A. L., Merletti, F., Suárez-Varela, M. M., Trétarre, B., Wingren, G., Richiardi, L. & Sabroe, S., 2019, In : Cancer Epidemiology. 61, p. 133-138 6 p.

    Research output: Contribution to journalArticle

  4. 2018
  5. Adjuvant chemotherapy and postoperative radiotherapy in high-risk soft tissue sarcoma patients defined by biological risk factors—A Scandinavian Sarcoma Group study (SSG XX)

    Sundby Hall, K., Bruland, Ø. S., Bjerkehagen, B., Zaikova, O., Jacob Engellau, Oskar Hagberg, Hansson, L., Hagberg, H., Ahlström, M., Knobel, H., Papworth, K., Zemmler, M., Goplen, D., Bauer, H. C. F. & Mikael Eriksson, 2018 Aug 1, In : European Journal of Cancer. 99, p. 78-85 8 p.

    Research output: Contribution to journalArticle

  6. Working to improve the management of sarcoma patients across Europe: A policy checklist

    Kasper, B., Lecointe-Artzner, E., Wait, S., Boldon, S., Wilson, R., Gronchi, A., Valverde, C., Mikael Eriksson, Dumont, S., Drove, N., Kanli, A. & Wartenberg, M., 2018 Apr 16, In : BMC Cancer. 18, 1, 424.

    Research output: Contribution to journalArticle

  7. Expression of cell cycle regulators and frequency of TP53 mutations in high risk gastrointestinal stromal tumors prior to adjuvant imatinib treatment

    Ihle, M. A., Huss, S., Jeske, W., Hartmann, W., Merkelbach-Bruse, S., Schildhaus, H. U., Büttner, R., Sihto, H., Hall, K. S., Mikael Eriksson, Reichardt, P., Joensuu, H. & Wardelmann, E., 2018 Feb 1, In : PLoS ONE. 13, 2, e0193048.

    Research output: Contribution to journalArticle

  8. EURO-B.O.S.S. A European study on chemotherapy in bone-sarcoma patients aged over 40: Outcome in primary high-grade osteosarcoma

    Ferrari, S., Bielack, S. S., Smeland, S., Longhi, A., Egerer, G., Sundby Hall, K., Donati, D., Kevric, M., Brosjö, O., Comandone, A., Werner, M., Monge, O., Palmerini, E., Berdel, W. E., Bjerkehagen, B., Paioli, A., Lorenzen, S., Eriksson, M., Gambarotti, M., Tunn, P. U. & 13 othersJebsen, N. L., Cesari, M., von Kalle, T., Ferraresi, V., Schwarz, R., Bertulli, R., Kasparek, A. K., Grignani, G., Krasniqi, F., Sorg, B., Hecker-Nolting, S., Picci, P. & Reichardt, P., 2018 Jan 1, In : Tumori. 104, 1, p. 30-36 7 p.

    Research output: Contribution to journalArticle

  9. Occupational exposure to organic solvents and risk of male breast cancer: A European multicenter case-control study

    Laouali, N., Pilorget, C., Cyr, D., Neri, M., Kaerlev, L., Sabroe, S., Gorini, G., Richiardi, L., Morales-Suárez-Varela, M., Llopis-Gonzalez, A., Ahrens, W., Jöckel, K. H., Afonso, N., Mikael Eriksson, Merletti, F., Olsen, J., Lynge, E. & Guénel, P., 2018 Jan 1, In : Scandinavian Journal of Work, Environment and Health. 44, 3, p. 312-322 11 p.

    Research output: Contribution to journalArticle

  10. Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

    ESMO Guidelines Committee, PaedCan, Casali, P. G., Bielack, S., Abecassis, N., Aro, H. T., Bauer, S., Biagini, R., Bonvalot, S., Boukovinas, I., Bovee, J. V. M. G., Brennan, B., Brodowicz, T., Broto, J. M., Brugières, L., Buonadonna, A., De Álava, E., Dei Tos, A. P., Del Muro, X. G., Dileo, P. & 32 othersDhooge, C., M. Eriksson, Fagioli, F., Fedenko, A., Ferraresi, V., Ferrari, A., Ferrari, S., Frezza, A. M., Gaspar, N., Gasperoni, S., Gelderblom, H., Gil, T., Grignani, G., Gronchi, A., Haas, R. L., Hassan, B., Hecker-Nolting, S., Hohenberger, P., Issels, R., Joensuu, H., Jones, R. L., Judson, I., Jutte, P., Kaal, S., Kager, L., Kasper, B., Kopeckova, K., Krákorová, D. A., Ladenstein, R., Le Cesne, A., Lugowska, I. & Merimsky, O., 2018, In : Annals of Oncology. 29, p. iv79-iv95

    Research output: Contribution to journalArticle

  11. 2017
  12. The Scandinavian Sarcoma Group Central Register: 6,000 patients after 25 years of monitoring of referral and treatment of extremity and trunk wall soft-tissue sarcoma

    Trovik, C., Bauer, H. C. F., Styring, E., Sundby Hall, K., Vult Von Steyern, F., Eriksson, S., Johansson, I., Sampo, M., Laitinen, M., Kalén, A., Jónsson, H., Jebsen, N. L., Eriksson, M., Tukiainen, E., Wall, N., Zaikova, O., Sigurðsson, H., Lehtinen, T., Bjerkehagen, B., Skorpil, M. & 3 othersEgil Eide, G., Johansson, E. & Thor A. Alvegard, 2017 Mar 7, In : Acta Orthopaedica. p. 1-7 7 p.

    Research output: Contribution to journalArticle

  13. Effect of KIT and PDGFRA mutations on survival in patients with gastrointestinal stromal tumors treated with adjuvant imatinib: An exploratory analysis of a randomized clinical trial

    Joensuu, H., Wardelmann, E., Sihto, H., Mikael Eriksson, Sundby Hall, K., Reichardt, A., Hartmann, J. T., Pink, D., Cameron, S., Hohenberger, P., Al-Batran, S-E., Schlemmer, M., Bauer, S., Nilsson, B., Kallio, R., Junnila, J., Vehtari, A. & Reichardt, P., 2017, In : JAMA oncology. 3, 5, p. 602-609 8 p.

    Research output: Contribution to journalArticle

  14. 2016
  15. Plasma immunoprofiling of patients with high-risk diffuse large B-cell lymphoma: a Nordic Lymphoma Group study

    Pauly, F., Fjordén, K., Leppä, S., Holte, H., Björkholm, M., Fluge, Møller Pedersen, L., M. Eriksson, A. Isinger-Ekstrand, C. A.K. Borrebaeck, M. Jerkeman & C. Wingren, 2016 Nov 18, In : Blood Cancer Journal. 6, 11, p. e501

    Research output: Contribution to journalArticle

  16. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer

    Hollestelle, A., Van Der Baan, F. H., Berchuck, A., Johnatty, S. E., Aben, K. K., Agnarsson, B. A., Aittomäki, K., Alducci, E., Andrulis, I. L., Anton-Culver, H., Antonenkova, N. N., Antoniou, A. C., Apicella, C., Arndt, V., Arnold, N., Arun, B. K., Arver, B., Ashworth, A., Baglietto, L., Balleine, R. & 343 othersBandera, E. V., Barrowdale, D., Bean, Y. T., Beckmann, L., Beckmann, M. W., Benitez, J., Berger, A., Berger, R., Beuselinck, B., Bisogna, M., Bjorge, L., Blomqvist, C., Bogdanova, N. V., Bojesen, A., Bojesen, S. E., Bolla, M. K., Bonanni, B., Brand, J. S., Brauch, H., Brenner, H., Brinton, L., Brooks-Wilson, A., Bruinsma, F., Brunet, J., Brüning, T., Budzilowska, A., Bunker, C. H., Burwinkel, B., Butzow, R., Buys, S. S., Caligo, M. A., Campbell, I., Carter, J., Chang-Claude, J., Chanock, S. J., Claes, K. B. M., Collée, J. M., Cook, L. S., Couch, F. J., Cox, A., Cramer, D., Cross, S. S., Cunningham, J. M., Cybulski, C., Czene, K., Damiola, F., Dansonka-Mieszkowska, A., Darabi, H., De La Hoya, M., Defazio, A., Dennis, J., Devilee, P., Dicks, E. M., Diez, O., Doherty, J. A., Domchek, S. M., Dorfling, C. M., Dörk, T., Silva, I. D. S., Du Bois, A., Dumont, M., Dunning, A. M., Duran, M., Easton, D. F., Eccles, D., Edwards, R. P., Hans Ehrencrona, Ejlertsen, B., Ekici, A. B., Ellis, S. D., Engel, C., Mikael Eriksson, Fasching, P. A., Feliubadalo, L., Figueroa, J., Flesch-Janys, D., Fletcher, O., Fontaine, A., Fortuzzi, S., Fostira, F., Fridley, B. L., Friebel, T., Friedman, E., Friel, G., Frost, D., Garber, J., García-Closas, M., Gayther, S. A., Gentry-Maharaj, A., Gerdes, A. M., Giles, G. G., Glasspool, R., Glendon, G., Godwin, A. K., Goodman, M. T., Gore, M., Greene, M. H., Grip, M., Gronwald, J., Gschwantler Kaulich, D., Guénel, P., Guzman, S. R., Haeberle, L., Haiman, C. A., Hall, P., Halverson, S. L., Hamann, U., Hansen, T. V. O., Harter, P., Hartikainen, J. M., Healey, S., Hein, A., Heitz, F., Henderson, B. E., Herzog, J., T Hildebrandt, M. A., Høgdall, C. K., Høgdall, E., Hogervorst, F. B. L., Hopper, J. L., Humphreys, K., Huzarski, T., Imyanitov, E. N., Isaacs, C., Jakubowska, A., Janavicius, R., Jaworska, K., Jensen, A., Jensen, U. B., Johnson, N., Jukkola-Vuorinen, A., Kabisch, M., Karlan, B. Y., Kataja, V., Kauff, N., Kelemen, L. E., Kerin, M. J., Kiemeney, L. A., Kjaer, S. K., Knight, J. A., Knol-Bout, J. P., Konstantopoulou, I., Kosma, V. M., Krakstad, C., Kristensen, V., Kuchenbaecker, K. B., Kupryjanczyk, J., Laitman, Y., Lambrechts, D., Lambrechts, S., Larson, M. C., Lasa, A., Laurent-Puig, P., Lazaro, C., Le, N. D., Le Marchand, L., Leminen, A., Lester, J., Levine, D. A., Li, J., Liang, D., Lindblom, A., Lindor, N., Lissowska, J., Long, J., Lu, K. H., Lubinski, J., Lundvall, L., Lurie, G., Mai, P. L., Mannermaa, A., Margolin, S., Mariette, F., Marme, F., Martens, J. W. M., Massuger, L. F. A. G., Maugard, C., Mazoyer, S., McGuffog, L., McGuire, V., McLean, C., McNeish, I., Meindl, A., Menegaux, F., Menéndez, P., Menkiszak, J., Menon, U., Mensenkamp, A. R., Miller, N., Milne, R. L., Modugno, F., Montagna, M., Moysich, K. B., Müller, H., Mulligan, A. M., Muranen, T. A., Narod, S. A., Nathanson, K. L., Ness, R. B., Neuhausen, S. L., Nevanlinna, H., Neven, P., Nielsen, F. C., Nielsen, S. F., Nordestgaard, B. G., Nussbaum, R. L., Odunsi, K., Offit, K., Olah, E., Olopade, O. I., Olson, J. E., Olson, S. H., Oosterwijk, J. C., Orlow, I., Orr, N., Orsulic, S., Osorio, A., Ottini, L., Paul, J., Pearce, C. L., Pedersen, I. S., Peissel, B., Pejovic, T., Pelttari, L. M., Perkins, J., Permuth-Wey, J., Peterlongo, P., Peto, J., Phelan, C. M., Phillips, K. A., Piedmonte, M., Pike, M. C., Platte, R., Plisiecka-Halasa, J., Poole, E. M., Poppe, B., Pylkäs, K., Radice, P., Ramus, S. J., Rebbeck, T. R., Reed, M. W. R., Rennert, G., Risch, H. A., Robson, M., Rodriguez, G. C., Romero, A., Rossing, M. A., Rothstein, J. H., Rudolph, A., Runnebaum, I., Salani, R., Salvesen, H. B., Sawyer, E. J., Schildkraut, J. M., Schmidt, M. K., Schmutzler, R. K., Schneeweiss, A., Schoemaker, M. J., Schrauder, M. G., Schumacher, F., Schwaab, I., Scuvera, G., Sellers, T. A., Severi, G., Seynaeve, C. M., Shah, M., Shrubsole, M., Siddiqui, N., Sieh, W., Simard, J., Singer, C. F., Sinilnikova, O. M., Smeets, D., Sohn, C., Soller, M., Song, H., Soucy, P., Southey, M. C., Stegmaier, C., Stoppa-Lyonnet, D., Sucheston, L., Swerdlow, A., Tangen, I. L., Tea, M. K., Teixeira, M. R., Terry, K. L., Terry, M. B., Thomassen, M., Thompson, P. J., Tihomirova, L., Tischkowitz, M., Toland, A. E., Tollenaar, R. A. E. M., Tomlinson, I., Torres, D., Truong, T., Tsimiklis, H., Tung, N., Tworoger, S. S., Tyrer, J. P., Vachon, C. M., Van 't Veer, L. J., Van Altena, A. M., Van Asperen, C. J., Van Den Berg, D., Van Den Ouweland, A. M. W., Van Doorn, H. C., Van Nieuwenhuysen, E., Van Rensburg, E. J., Vergote, I., Verhoef, S., Vierkant, R. A., Vijai, J., Vitonis, A. F., Von Wachenfeldt, A., Walsh, C., Wang, Q., Wang-Gohrke, S., Wappenschmidt, B., Weischer, M., Weitzel, J. N., Weltens, C., Wentzensen, N., Whittemore, A. S., Wilkens, L. R., Winqvist, R., Wu, A. H., Wu, X., Yang, H. P., Zaffaroni, D., Pilar Zamora, M., Zheng, W., Ziogas, A., Chenevix-Trench, G., Pharoah, P. D. P., Rookus, M. A., Hooning, M. J., Goode, E. L., Breast Cancer Family Register, C. F. R., EMBRACE, GENICA Network, N., HEBON & SWE-BRCA, 2016 May 1, In : Gynecologic Oncology. 141, 2, p. 386-401 16 p.

    Research output: Contribution to journalArticle

  17. 15-year follow-up of the Second Nordic Mantle Cell Lymphoma trial (MCL2): Prolonged remissions without survival plateau

    Eskelund, C. W., Kolstad, A., Jerkeman, M., Räty, R., Laurell, A., Eloranta, S., Smedby, K. E., Husby, S., Pedersen, L. B., Andersen, N. S., Eriksson, M., Kimby, E., Bentzen, H., Kuittinen, O., Lauritzsen, G. F., Nilsson-Ehle, H., Ralfkiær, E., Ehinger, M., Sundström, C., Delabie, J. & 7 othersKarjalainen-Lindsberg, M. L., Workman, C. T., Garde, C., Elonen, E., Brown, P., Grønbæk, K. & Geisler, C. H., 2016, In : British Journal of Haematology. 175, 3, p. 410-418

    Research output: Contribution to journalArticle

  18. Needle biopsy through the abdominal wall for the diagnosis of gastrointestinal stromal tumour - Does it increase the risk for tumour cell seeding and recurrence?

    Mikael Eriksson, Reichardt, P., Sundby Hall, K., Schütte, J., Cameron, S., Hohenberger, P., Bauer, S., Leinonen, M., Reichardt, A., Rejmyr Davis, M., Thor Alvegård & Joensuu, H., 2016, In : European Journal of Cancer. 59, p. 128-133 6 p.

    Research output: Contribution to journalArticle

  19. 2015
  20. Adjuvant Imatinib for High-Risk GI Stromal Tumor: Analysis of a Randomized Trial.

    Joensuu, H., Mikael Eriksson, Sundby Hall, K., Reichardt, A., Hartmann, J. T., Pink, D., Ramadori, G., Hohenberger, P., Al-Batran, S-E., Schlemmer, M., Bauer, S., Wardelmann, E., Nilsson, B., Sihto, H., Bono, P., Kallio, R., Junnila, J., Thor Alvegård & Reichardt, P., 2015, In : Journal of Clinical Oncology.

    Research output: Contribution to journalArticle

  21. EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment.

    Whelan, J. S., Bielack, S. S., Marina, N., Smeland, S., Jovic, G., Hook, J. M., Krailo, M., Anninga, J., Butterfass-Bahloul, T., Böhling, T., Calaminus, G., Capra, M., Deffenbaugh, C., Dhooge, C., Eriksson, M., Flanagan, A. M., Gelderblom, H., Goorin, A., Gorlick, R., Gosheger, G. & 21 othersGrimer, R. J., Hall, K. S., Helmke, K., Hogendoorn, P. C., Jundt, G., Kager, L., Kuehne, T., Lau, C., Letson, G. D., Meyer, J., Meyers, P., Morris, C., Mottl, H., Nadel, H., Nagarajan, R., Randall, R. L., Schomberg, P., Schwarz, R., Teot, L. A., Sydes, M. R. & Bernstein, M., 2015, In : Annals of Oncology. 26, 2, p. 407-414

    Research output: Contribution to journalArticle

  22. F-18-fluorodeoxyglucose-positron emission tomography/computed tomography after one cycle of chemotherapy in patients with diffuse large B-cell lymphoma: results of a Nordic/US intergroup study

    Mylam, K. J., Kostakoglu, L., Hutchings, M., Coleman, M., Lamonica, D., Czuczman, M. S., Diehl, L. F., Nielsen, A. L., Jensen, P., Loft, A., Hendel, H. W., Iyer, V., Leppa, S., Jyrkkio, S., Holte, H., Eriksson, M., Gillstrom, D., Hansen, P. B., Seppanen, M., Hjorthaug, K. & 2 othersBrown, P. D. N. & Pedersen, L. M., 2015, In : Leukemia & Lymphoma. 56, 7, p. 2005-2012

    Research output: Contribution to journalArticle

  23. HSP90 inhibition blocks ERBB3 and RET phosphorylation in myxoid/round cell liposarcoma and causes massive cell death in vitro and in vivo.

    Safavi, S., Järnum, S., Vannas, C., Udhane, S., Jonasson, E., Tomic, T. T., Grundevik, P., Fagman, H., Hansson, M., Kalender, Z., Jauhiainen, A., Dolatabadi, S., Stratford, E. W., Myklebost, O., Mikael Eriksson, Stenman, G., Stock, R. S., Ståhlberg, A. & Åman, P., 2015, In : Oncotarget.

    Research output: Contribution to journalArticle

  24. Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial.

    Bielack, S. S., Smeland, S., Whelan, J. S., Marina, N., Jovic, G., Hook, J. M., Krailo, M. D., Gebhardt, M., Pápai, Z., Meyer, J., Nadel, H., Randall, R. L., Deffenbaugh, C., Nagarajan, R., Brennan, B., Letson, G. D., Teot, L. A., Goorin, A., Baumhoer, D., Kager, L. & 29 othersWerner, M., Lau, C. C., Sundby Hall, K., Gelderblom, H., Meyers, P., Gorlick, R., Windhager, R., Helmke, K., Mikael Eriksson, Hoogerbrugge, P. M., Schomberg, P., Tunn, P-U., Kühne, T., Jürgens, H., van den Berg, H., Böhling, T., Picton, S., Renard, M., Reichardt, P., Gerss, J., Butterfass-Bahloul, T., Morris, C., Hogendoorn, P. C. W., Seddon, B., Calaminus, G., Michelagnoli, M., Dhooge, C., Sydes, M. R. & Bernstein, M., 2015, In : Journal of Clinical Oncology. 33, 20, p. 2279-U92

    Research output: Contribution to journalArticle

  25. Post-Relapse Survival in Patients With Ewing Sarcoma

    Ferrari, S., Luksch, R., Hall, K. S., Fagioli, F., Prete, A., Tamburini, A., Tienghi, A., DiGirolamo, S., Paioli, A., Abate, M. E., Podda, M., Cammelli, S., Mikael Eriksson & del Prever, A. B., 2015, In : Pediatric Blood & Cancer. 62, 6, p. 994-999

    Research output: Contribution to journalArticle

  26. Radiotherapy for GIST progressing during or after tyrosine kinase inhibitor therapy: A prospective study.

    Joensuu, H., Mikael Eriksson, Collan, J., Balk, M. H., Leyvraz, S. & Montemurro, M., 2015, In : Radiotherapy and Oncology. 116, 2, p. 233-238

    Research output: Contribution to journalArticle

  27. Referral patterns, treatment and outcome of high-grade malignant bone sarcoma in Scandinavia-SSG Central Register 25 years' experience.

    Zaikova, O., Sundby Hall, K., Emelie Styring, Mikael Eriksson, Trovik, C. S., Bergh, P., Bjerkehagen, B., Skorpil, M., Weedon-Fekjaer, H. & Bauer, H. C. F., 2015, In : Journal of Surgical Oncology. 112, 8, p. 853-860

    Research output: Contribution to journalArticle

  28. Successful change of treatment strategy in elderly patients with primary central nervous system lymphoma by de-escalating induction and introducing temozolomide maintenance: results from a phase 2 study by The Nordic Lymphoma Group.

    Pulczynski, E. J., Kuittinen, O., Erlanson, M., Hagberg, H., Fosså, A., Mikael Eriksson, Nordstrøm, M., Ostenstad, B., Fluge, O., Leppä, S., Fiirgaard, B., Bersvendsen, H. & Fagerli, U-M., 2015, In : Haematologica. 100, 4, p. 537-543

    Research output: Contribution to journalArticle

  29. 2014
  30. Deregulation of COMMD1 Is Associated with Poor Prognosis in Diffuse Large B-cell Lymphoma.

    Taskinen, M., Louhimo, R., Koivula, S., Chen, P., Rantanen, V., Holte, H., Delabie, J., Karjalainen-Lindsberg, M-L., Björkholm, M., Fluge, O., Pedersen, L. M., Fjordén, K., Mats Jerkeman, Mikael Eriksson, Hautaniemi, S. & Leppä, S., 2014, In : PLoS ONE. 9, 3, e91031.

    Research output: Contribution to journalArticle

  31. Gastrointestinal Stromal Tumor: A Method for Optimizing the Timing of CT Scans in the Follow-up of Cancer Patients.

    Joensuu, H., Reichardt, P., Mikael Eriksson, Hall, K. S. & Vehtari, A., 2014, In : Radiology. 271, 1, p. 96-103

    Research output: Contribution to journalArticle

  32. High-Dose Chemotherapy with Stem Cell Rescue in the Primary Treatment of Metastatic and Pelvic Osteosarcoma: Final Results of the ISG/SSG II Study

    Boye, K., Del Prever, A. B., Mikael Eriksson, Saeter, G., Tienghi, A., Lindholm, P., Fagioli, F., Skjeldal, S., Ferrari, S. & Hall, K. S., 2014, In : Pediatric Blood & Cancer. 61, 5, p. 840-845

    Research output: Contribution to journalArticle

  33. Risk Factors for Gastrointestinal Stromal Tumor Recurrence in Patients Treated With Adjuvant Imatinib

    Joensuu, H., Mikael Eriksson, Hall, K. S., Hartmann, J. T., Pink, D., Schuette, J., Ramadori, G., Hohenberger, P., Duyster, J., Al-Batran, S-E., Schlemmer, M., Bauer, S., Wardelmann, E., Sarlomo-Rikala, M., Nilsson, B., Sihto, H., Ballman, K. V., Leinonen, M., DeMatteo, R. P. & Reichardt, P., 2014, In : Cancer. 120, 15, p. 2325-2333

    Research output: Contribution to journalArticle

  34. 2013
  35. Benefits and Adverse Events in Younger Versus Older Patients Receiving Neoadjuvant Chemotherapy for Osteosarcoma: Findings From a Meta-Analysis.

    Collins, M., Wilhelm, M., Conyers, R., Herschtal, A., Whelan, J., Bielack, S., Kager, L., Kühne, T., Sydes, M., Gelderblom, H., Ferrari, S., Picci, P., Smeland, S. E. R., Mikael Eriksson, Petrilli, A. S., Bleyer, A. & Thomas, D. M., 2013, In : Journal of Clinical Oncology. 31, 18, p. 2303-U130

    Research output: Contribution to journalArticle

  36. Dose-densified chemoimmunotherapy followed by systemic central nervous system prophylaxis for younger high-risk diffuse large B-cell/follicular grade 3 lymphoma patients: results of a phase II Nordic Lymphoma Group study

    Holte, H., Leppa, S., Bjorkholm, M., Fluge, O., Jyrkkio, S., Delabie, J., Sundstrom, C., Karjalainen-Lindsberg, M. -L., Erlanson, M., Kolstad, A., Fossa, A., Ostenstad, B., Lofvenberg, E., Nordstrom, M., Janes, R., Pedersen, L. M., Anderson, H., Mats Jerkeman & Mikael Eriksson, 2013, In : Annals of Oncology. 24, 5, p. 1385-1392

    Research output: Contribution to journalArticle

  37. 2012
  38. Epidemiological Studies on Cancer and Exposure to Dioxins and Related Compounds

    Hardell, L. & Mikael Eriksson, 2012 Mar 30, Dioxins and Health: Including Other Persistent Organic Pollutants and Endocrine Disruptors: Third Edition. John Wiley & Sons, p. 303-358 56 p.

    Research output: Chapter in Book/Report/Conference proceedingBook chapter

  39. Adjuvant therapy in primary GIST: state-of-the-art

    Reichardt, P., Blay, J. -Y., Boukovinas, I., Brodowicz, T., Broto, J. M., Casali, P. G., Decatris, M., Mikael Eriksson, Gelderblom, H., Kosmidis, P., Le Cesne, A., Pousa, A. L., Schlemmer, M., Verweij, J. & Joensuu, H., 2012, In : Annals of Oncology. 23, 11, p. 2776-2781

    Research output: Contribution to journalReview article

  40. High serum vascular endothelial growth factor level is an adverse prognostic factor for high-risk diffuse large B-cell lymphoma patients treated with dose-dense chemoimmunotherapy

    Riihijarvi, S., Nurmi, H., Holte, H., Bjorkholm, M., Fluge, O., Pedersen, L. M., Fjordén, K., Mats Jerkeman, Mikael Eriksson & Leppa, S., 2012, In : European Journal of Haematology. 89, 5, p. 395-402

    Research output: Contribution to journalArticle

  41. Nordic MCL2 trial update: six-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC plus autologous stem-cell support: still very long survival but late relapses do occur

    Geisler, C. H., Kolstad, A., Laurell, A., Jerkeman, M., Raty, R., Andersen, N. S., Pedersen, L. B., Eriksson, M., Nordstrom, M., Kimby, E., Bentzen, H., Kuittinen, O., Lauritzsen, G. F., Nilsson-Ehle, H., Ralfkiaer, E., Ehinger, M., Sundstrom, C., Delabie, J., Karjalainen-Lindsberg, M-L., Brown, P. & 1 othersElonen, E., 2012, In : British Journal of Haematology. 158, 3, p. 355-362

    Research output: Contribution to journalArticle

  42. Occupational exposure to endocrine-disrupting chemicals and the risk of uveal melanoma

    Behrens, T., Lynge, E., Cree, I., Lutz, J-M., Mikael Eriksson, Guenel, P., Merletti, F., Morales-Suarez-Varela, M., Afonso, N., Stengrevics, A., Stang, A., Fevotte, J., Sabroe, S., Llopis-Gonzalez, A., Gorini, G., Hardell, L. & Ahrens, W., 2012, In : Scandinavian Journal of Work, Environment and Health. 38, 5, p. 476-483

    Research output: Contribution to journalArticle

  43. One vs Three Years of Adjuvant Imatinib for Operable Gastrointestinal Stromal Tumor A Randomized Trial

    Joensuu, H., Eriksson, M., Hall, K. S., Hartmann, J. T., Pink, D., Schuette, J., Ramadori, G., Hohenberger, P., Duyster, J., Al-Batran, S-E., Schlemmer, M., Bauer, S., Wardelmann, E., Sarlomo-Rikala, M., Nilsson, B., Sihto, H., Monge, O. R., Bono, P., Kallio, R., Vehtari, A. & 3 othersLeinonen, M., Thor Alvegård & Reichardt, P., 2012, In : JAMA: the journal of the American Medical Association. 307, 12, p. 1265-1272

    Research output: Contribution to journalArticle

  44. Pesticide exposure in farming and forestry and the risk of uveal melanoma

    Behrens, T., Lynge, E., Cree, I., Lutz, J-M., Mikael Eriksson, Guenel, P., Merletti, F., Morales-Suarez-Varela, M., Afonso, N., Stengrevics, A., Fevotte, J., Sabroe, S., Llopis-Gonzalez, A., Gorini, G., Hardell, L., Stang, A. & Ahrens, W., 2012, In : Cancer Causes and Control. 23, 1, p. 141-151

    Research output: Contribution to journalArticle

  45. Primary metastatic Ewing's family tumors: results of the Italian Sarcoma Group and Scandinavian Sarcoma Group ISG/SSG IV Study including myeloablative chemotherapy and total-lung irradiation

    Luksch, R., Tienghi, A., Hall, K. S., Fagioli, F., Picci, P., Barbieri, E., Gandola, L., Mikael Eriksson, Ruggieri, P., Daolio, P., Lindholm, P., Prete, A., Bisogno, G., Tamburini, A., Grignani, G., Abate, M. E., Podda, M., Smeland, S. & Ferrari, S., 2012, In : Annals of Oncology. 23, 11, p. 2970-2976

    Research output: Contribution to journalArticle

  46. 2011
  47. Nordic MCL2 Trial of 1St-Line Intensive Immunochemotherapy and Autologous Stem Cell Transplantation in Mantle Cell Lymphoma: Still Encouraging Results After Median 5½ Years Observation Time

    Geisler, C. H., Kolstad, A., Laurell, A., Raty, R., Jerkeman, M., Eriksson, M., Nordstrom, M., Kimby, E., Bentzen, H. E. N., Nilsson-Ehle, H., Kuittinen, O., Lauritzsen, G. F., Ralfkiaer, E., Ehinger, M., Sundstrom, C., Delabie, J., Karjalainen-Lindsberg, M. -L., Pedersen, L. B., Andersen, N. S., Brown, P. D. N. & 1 othersElonen, E., 2011, In : Biology of Blood and Marrow Transplantation. 17, 2, p. 196-196

    Research output: Contribution to journalPublished meeting abstract

  48. 2010
  49. Exon Based Transcriptome Profiling Reveals Genes That Have Prognostic Impact on the Survival of Young High Risk Diffuse Large B Cell/Follicular Grade 3 Lymphoma Patients Treated with Dose Dense Chemoimmuno therapy and CNS Prophylaxis Results From a Nordic Lymphoma Group Phase II Study

    Koivula, S., Taskinen, M., Chen, P., Holte, H., Delabie, J., Lindsberg, M. L. K., Bjorkholm, M., Fluge, O., Pedersen, L. M., Mats Jerkeman, Mikael Eriksson, Hautaniemi, S. & Leppa, S., 2010, In : Blood. 116, 21, p. 1281-1281

    Research output: Contribution to journalPublished meeting abstract

  50. High Serum Vascular Endothelial Growth Factor (VEGF) Level Is An Adverse Prognostic Factor In High Risk Diffuse Large B Cell Lymphoma (DLBCL) Patients Treated with Dose Dense Chemoimmunotherapy and Systemic CNS Prophylaxis Results From a Nordic Phase II Study

    Riihuarvi, S., Nyman, H., Holte, H., Bjorkholm, M., Fluge, O., Pedersen, L. M., Mats Jerkeman, Mikael Eriksson & Leppa, S., 2010, In : Blood. 116, 21, p. 1686-1686

    Research output: Contribution to journalPublished meeting abstract

  51. Histology-driven chemotherapy of soft-tissue sarcoma.

    Mikael Eriksson, 2010, In : Annals of Oncology. 21 Suppl 7, p. 270-276

    Research output: Contribution to journalArticle

  52. Hormonal exposures and the risk of uveal melanoma

    Behrens, T., Kaerlev, L., Cree, I., Lutz, J-M., Afonso, N., Mikael Eriksson, Guenel, P., Merletti, F., Morales-Suarez-Varela, M., Stengrevics, A., Sabroe, S., Cyr, D., Llopis-Gonzalez, A., Gorini, G., Sharkova, G., Hardell, L. & Ahrens, W., 2010, In : Cancer Causes and Control. 21, 10, p. 1625-1634

    Research output: Contribution to journalArticle

  53. Occupational exposure to electromagnetic fields and sex-differential risk of uveal melanoma

    Behrens, T., Lynge, E., Cree, I., Sabroe, S., Lutz, J-M., Afonso, N., Mikael Eriksson, Guenel, P., Merletti, F., Morales-Suarez-Varela, M., Stengrevics, A., Fevotte, J., Llopis-Gonzalez, A., Gorini, G., Sharkova, G., Hardell, L. & Ahrens, W., 2010, In : Occupational and Environmental Medicine. 67, 11, p. 751-759

    Research output: Contribution to journalArticle

  54. Occupation and occupational exposure to endocrine disrupting chemicals in male breast cancer: a case-control study in Europe

    Villeneuve, S., Cyr, D., Lynge, E., Orsi, L., Sabroe, S., Merletti, F., Gorini, G., Morales-Suarez-Varela, M., Ahrens, W., Baumgardt-Elms, C., Kaerlev, L., Mikael Eriksson, Hardell, L., Fevotte, J. & Guenel, P., 2010, In : Occupational and Environmental Medicine. 67, 12, p. 837-844

    Research output: Contribution to journalArticle

  55. The Mantle Cell Lymphoma International Prognostic Index (MIPI) is superior to the International Prognostic Index (IPI) in predicting survival following intensive first-line immunochemotherapy and autologous stem cell transplantation (ASCT)

    Geisler, C. H., Kolstad, A., Laurell, A., Raty, R., Mats Jerkeman, Mikael Eriksson, Nordstrom, M., Kimby, E., Boesen, A. M., Nilsson-Ehle, H., Kuittinen, O., Lauritzsen, G. F., Ralfkiaer, E., Mats Ehinger, Sundstrom, C., Delabie, J., Karjalainen-Lindsberg, M-L., Brown, P. & Elonen, E., 2010, In : Blood. 115, 8, p. 1530-1533

    Research output: Contribution to journalArticle

  56. 2009
  57. Adjuvant systemic therapy of gastrointestinal stromal tumors The Scandinavian Sarcoma Group perspective

    Joensuu, H. & Mikael Eriksson, 2009, In : Acta Orthopaedica. 80, p. 37-43

    Research output: Contribution to journalArticle

  58. A European treatment protocol for bone sarcoma in patients older than 40 years

    Ferrari, S., Smeland, S., Bielack, S., Comandone, A., Dileo, P., Picci, P., Hall, K. S., Mikael Eriksson, Honegger, H. & Reichardt, P., 2009, In : Journal of Clinical Oncology. 27, 15

    Research output: Contribution to journalPublished meeting abstract

  59. Concentrations of organohalogen compounds and titres of antibodies to Epstein-Barr virus antigens and the risk for non-Hodgkin lymphoma

    Hardell, K., Carlberg, M., Hardell, L., Bjornfoth, H., Jogsten, I. E., Mikael Eriksson, Van Bavel, B. & Lindstrom, G., 2009, In : Oncology Reports. 21, 6, p. 1567-1576

    Research output: Contribution to journalArticle

  60. Pre-Emptive Treatment With Rituximab of Molecular Relapse After Autologous Stem Cell Transplantation in Mantle Cell Lymphoma.

    Andersen, N. S., Pedersen, L. B., Laurell, A., Elonen, E., Kolstad, A., Boesen, A. M., Pedersen, L. M., Lauritzsen, G. F., Ekanger, R., Nilsson-Ehle, H., Nordström, M., Fredén, S., Mats Jerkeman, Mikael Eriksson, Väärt, J., Malmer, B. & Geisler, C. H., 2009, In : Journal of Clinical Oncology. 27, p. 4365-4370

    Research output: Contribution to journalArticle

Previous 1 2 Next